Optimization of evening insulin dose in patients using the short-acting insulin analog lispro

Diabetes Care

Volumn 21, Issue 7, 1998, Pages 1162-1166

  Ahmed, Abu Baker E ^a   Mallias, John ^a   Home, Philip D ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN LISPRO; ISOPHANE INSULIN; NEUTRAL INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE TIME EFFECT RELATION; DRUG EFFICACY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MALE; MEAL; NIGHT; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

3-HYDROXYBUTYRIC ACID; ADULT; BLOOD GLUCOSE; CIRCADIAN RHYTHM; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYDROXYBUTYRATES; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN, ISOPHANE; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD;

EID: 0031869884     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.7.1162     Document Type: Article

References (26)

1. Howey DC, Bowsher RR, Brunelle RL, Woodworth JR: Lispro human insulin: a rapidly absorbed analog of human insulin. Diabetes 43:396-402, 1994
2. Heinemann L, Starke AAR, Heding L, Jensen I, Berger M: Action profiles of fast onset insulin analogues. Diabetologia 33:384-386, 1990
3. Torlone E, Fanelli C, Rambotti AM, Kassi G, Modarelli F, Di Vincenzo A, Epifano L, Ciofetta M, Pampabelli S, Brunetti P, Bolli GN: Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28), Pro(B29)] in IDDM. Diabetologia 37:713-720, 1994
4. Burge M, Waters DL, Holcombe JH: Prolonged efficacy of short-acting insulin lispro in combination with human Ultratard in insulin dependent diabetes mellitus. J Clin Endocrinol Metab 82:920-924, 1997
5. Torlone E, Modarelli F, Pampanelli S, Epifano L, Lalli C, Kassi G, Del Sindaco P, Perriello G, Di Vincenzo A, Brunetti P, Rambotti AM, Bolli G: Effects of the short-acting insulin analog [Lys(B28),Pro(B29)] on postprandial blood glucose control in IDDM. Diabetes Care 19:945-952, 1996
6. Pampanelli S, Torlone E, Lalli C, Del Sindaco P, Cioffetta M, Lepore M, Bartocci L, Brunetti P, Bolli G: Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic B-cell function. Diabetes Care 18:1452-1460, 1995
7. Heinemann L, Heise T, Wahl LC, Trautmann ME, Starke AAR: Prandial glycaemia after a carbohydrate-rich meal in type 1 diabetic patients: using the rapid acting insulin analogue [Lys(B28), Pro(P29)] human insulin. Diabet Med 13:625-629, 1996
8. Carg SK, Carmain JA, Braddy KG, Anderson JH, Vignati L, Jennings MK, Chase HP: Pre-meal insulin analogue insulin lispro vs. Humulin R insulin treatment in young subjects with type 1 diabetes. Diabet Med 13:47-52, 1996
9. Pfützner A, Kustner E, Forst T, Schulze-Schleppinghoff B, Trautmann ME, Haslbeck M, Schatz H, Beyer J: Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes. Exp Clin Endocrinol 104:25-30, 1996
10. Anderson JH, Jr., Brunelle RL, Koivisto VA, Pfützner A, Trautmann ME: Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Diabetes 46:265-270, 1997
11. Ahmed ABE, Home PD: The effect of the insulin analog lispro on nighttime blood glucose control in type 1 diabetic patients. Diabetes Care 21:32-37, 1998
12. Hanning I, Home PD, Alberti KGMM: Measurement of free insulin concentration: the influence of the Liming of extraction of insulin antibodies. Diabetologia 28:831-835, 1985
13. Soeldner JS, Slone D: Critical variables in the radioimmunoassay of serum insulin using the double antibody technic. Diabetes 14:771-779, 1965
14. Harrison J, Hodson AW, Skillen AW, Stappenbeck R, Agius L, Alberti KGMM: Blood glucose, lactate, pyruvate, glycerol, 3-hydroxybutyrate, and acetoacetate measurements in man using a centrifugal analyser with fluorimetric attachment. J Chem Clin Biochem 26:141-146, 1988
15. Burge MR, Castillo KR, Schade DS: Meal composition is a determinant of lisproinduced hypoglycemia in IDDM. Diabetes Care 20:152-155, 1997
16. Patrick AW, Collier A, Matthews DM, Macintyre CCA, Clarke BF: The importance of the time interval between insulin injection and breakfast in determining postprandial glycaemic control: a comparison between human and porcine insulin. Diabet Med 5:32-35, 1988
17. Dimitriadis G, Gerich J: Importance of timing of preprandial subcutaneous insulin administration in the management of diabetes mellitus. Diabetes Care 6:374-377, 1985
18. Lean MEJ, Ng LL, Tennison BR: Interval between insulin injection and eating in relation to blood glucose control in adult diabetics. Br Med J 290:105-108, 1985
19. Berger M, Cuppers HJ, Hegner H, Jörgens V, Berchtold P: Absorption kinetics and biologic effects of subcutaneous injected insulin preparations. Diabetes Care 5:77-91, 1982
20. Gardner DR Arakaki RF, Podet EJ, Nell LJ, Thomas JW, Field JB: The pharmacokinetics of subcutaneous regular insulin in type 1 diabetic patients: assessment using glucose clamp technique. J Clin Endocrinol Metab 63:689-694, 1986
21. Home PD, Pickup JC, Keen H, Alberti KGMM, Parson JA, Binder C: Continuous subcutaneous insulin infusion: comparison of plasma insulin profile after infusion or bolus injection of mealtime dose. Metabolism 30:439-442, 1981
22. Jörgensen LN, Nielsen FS: Timing of premeal insulins in diabetic patients on a multiple daily injection regimen: a questionnaire study (Abstract). Diabetologia 33 (Suppl. 1):A116, 1990
23. Berger M, Heinemann L: Are presently available insulin analogues clinically beneficial? (Letter) Diabet Med 40 (Suppl. 2):S91-S96, 1997
24. Heinemann L: Do insulin treated diabetic patients use an injection-meal interval in daily life? (Letter) Diabet Med 12:449-450, 1995
25. Heinemann L, Starke AAR, Hohmann A, Berger M: Timing between the subcutaneous administration of insulin and consumption of a carbohydrate rich meal. Horm Metab Res 10 (Suppl. 26):137-139, 1992
26. Ebeling P, Jansson PA, Smith U, Lalli C, Bolli GB, Koivisto VA: Strategies toward improved control during insulin lispro therapy in IDDM: importance of basal insulin. Diabetes Care 20:1287-1289, 1997